AUXL/BSTC/Xiaflex data in Peyronie disease. Stock is up 10% pre market. http://www.reuters.com/article/2012/06/04/auxiliumpharma-study-xiaflex-idUSL3E8H45YY20120604?type=companyNews&feedType=RSS&feedName=companyNews&rpc=43